PAX-99379-43284
2 vaccinations
1 coded response
13 check-ins
1 free-text entry
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 235 / VA
- Registered
- 2022-06-20
- Relationship
- Child or adolescent in my care
- Guardian
- L6A-14808-52862
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-20
Registered in v-safe
-
2022-06-25
Dose 1 — Pfizer-BioNTech
-
2022-07-16
Dose 2 — Pfizer-BioNTech
- 2022-07-17
- 2022-07-18
-
2022-07-19
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Poor · Fever · Vomiting · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-07-21
- 2022-07-22
- 2022-07-23
- 2022-08-01
- 2022-08-06
-
2022-08-15
Survey response — day 28, dose 2, dependentMedDRA: Fungal infection, Nasopharyngitis, Respiratory syncytial virus infection — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: RSV or a cold or both (not Covid!) and a yeast infectionMedDRA releases: 2024-11 · check-in free text available
-
2022-08-15
Report sent to call center — day 28, dose 2, dependentGet care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-08-16
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-08-20
- 2022-08-27
- 2022-10-15
- 2023-01-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-25 | Pfizer-BioNTech | No |
| 2 | 2022-07-16 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 12 — day 28, dose 2, dependent
Symptoms: RSV or a cold or both (not Covid!) and a yeast infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fungal infection | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release